Published: June 2011
Publications
Medicines Monitoring - Reminder to Report
Prescriber Update 32(2): 18
June 2011
WE NEED YOUR HELP!
Please send your reports for these potential safety issues* listed in the table below.
| Medicine | Potential safety issue | Active monitoring period ends* |
|---|---|---|
| Rivaroxaban | Atrial fibrillation | 1 September 2011 |
| Simvastatin | Joint pain and swelling | 1 September 2011 |
| Quetiapine | Cardiomyopathy | 1 September 2011 |
-
is a Medsafe scheme designed to collect more information on potential
safety signals for specific medicines. - Safety signals are identified from reports of adverse medicine reactions sent to the Centre for Adverse Reactions Monitoring (CARM). For further information see the Medsafe website.
- The
scheme does not replace routine adverse reaction reporting. Find
out how to report at:
https://nzphvc.otago.ac.nz/report/
or www.medsafe.govt.nz/safety/report-a-probelm.asp
*The appearance of a possible safety issue in this scheme does not mean Medsafe and CARM have concluded that this medicine causes the reaction.
